An experimental Alzheimer's drug reverses genetic changes thought to spur the disease

An experimental Alzheimer's drug reverses genetic changes thought to spur the disease:

Dementia Big
Aging takes its toll on the brain, and the cells of the hippocampus—a brain region with circuitry crucial to learning and memory—are particularly vulnerable to changes that can lead to Alzheimer’s disease or cognitive decline. With the hope of counteracting the changes that can lead to these two conditions, researchers at Rockefeller University and their colleagues have begun examining the effects of a drug known to affect this circuitry.

http://ift.tt/1X7A3fZ